Table 7.
Lipid Parameters of Dyslipidemia Patients Before Switching Treatment from Brand-Name to Generic Atorvastatin and 6 Months After Stratified by Indications for Dyslipidemia Treatment
| Factors | Baseline | 6th Month | Mean Differences | 95% CI | p value |
|---|---|---|---|---|---|
| Indications | |||||
| Primary (n = 398) | |||||
| Chol | 176.08 (48.27) | 167.08 (44.26) | −9.00 | −13.53, −4.46 | < 0.001 |
| Tg | 142.37 (68.81) | 143.76 (78.56) | 1.38 | −6.32, 9.10 | 0.723 |
| HDL | 52.04 (13.36) | 50.04 (13.14) | −2.00 | −3.04, −0.96 | < 0.001 |
| LDL | 111.61 (44.32) | 101.75 (44.48) | −9.85 | −14.05, −5.64 | < 0.001 |
| Secondary (n = 90) | |||||
| Chol | 166.15 (55.43) | 161.46 (44.25) | −4.69 | −14.30, 4.91 | 0.332 |
| Tg | 153.93 (74.10) | 155.14 (71.40) | 1.20 | −12.78, 15.18 | 0.864 |
| HDL | 49.48 (13.72) | 46.67 (12.25) | −2.80 | −5.28, −0.32) | 0.027 |
| LDL | 103.33 (46.11) | 96.48 (35.81) | −6.84 | −14.51, 0.83 | 0.079 |
Abbreviations: CI, confidence interval; Chol, cholesterol (mg/dL); Tg, triglyceride (mg/dL); HDL, high-density lipoprotein-cholesterol (mg/dL); LDL, low-density lipoprotein-cholesterol (mg/dL).